152 related articles for article (PubMed ID: 31509035)
1. Microsponges enriched gel for enhanced topical delivery of 5-fluorouracil.
Jain SK; Kaur M; Kalyani P; Mehra A; Kaur N; Panchal N
J Microencapsul; 2019 Nov; 36(7):677-691. PubMed ID: 31509035
[TBL] [Abstract][Full Text] [Related]
2. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
Maiti S; Kaity S; Ray S; Sa B
Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
[TBL] [Abstract][Full Text] [Related]
4. The transport effect of submicron emulsions on 5-flurouracil topical application.
Huang YB; Huang CT; Tsou HY; Fu LT; Fu YS; Tsai YH; Wu PC
J Microencapsul; 2013; 30(5):425-31. PubMed ID: 23510368
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
6. Development, characterization and in vivo localization study of topical 5-fluorouracil gels: a comparative study with conventional formulation.
Jain SK; Puri R
Curr Drug Deliv; 2014; 11(3):401-14. PubMed ID: 24328603
[TBL] [Abstract][Full Text] [Related]
7. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Shakeel F; Haq N; Al-Dhfyan A; Alanazi FK; Alsarra IA
Drug Deliv; 2015; 22(4):573-80. PubMed ID: 24350612
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation.
Levy S; Furst K; Chern W
Clin Ther; 2001 Jun; 23(6):901-7. PubMed ID: 11440289
[TBL] [Abstract][Full Text] [Related]
10. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
[TBL] [Abstract][Full Text] [Related]
11. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation.
Hussain A; Samad A; Ramzan M; Ahsan MN; Ur Rehman Z; Ahmad FJ
Drug Deliv; 2016 May; 23(4):1115-29. PubMed ID: 25379805
[TBL] [Abstract][Full Text] [Related]
12. Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy.
Bothiraja C; Gholap AD; Shaikh KS; Pawar AP
Ther Deliv; 2014 Jul; 5(7):781-94. PubMed ID: 25287385
[TBL] [Abstract][Full Text] [Related]
13. [Microemulsion-based gel of fluorouracil for transdermal delivery].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
[TBL] [Abstract][Full Text] [Related]
14. Cellulose microsponges based gel of naringenin for atopic dermatitis: Design, optimization, in vitro and in vivo investigation.
Nagula RL; Wairkar S
Int J Biol Macromol; 2020 Dec; 164():717-725. PubMed ID: 32698069
[TBL] [Abstract][Full Text] [Related]
15. Quantification of 5-FU in skin samples for the development of new delivery systems for topical cancer treatment.
Petrilli R; Eloy JO; Paschoal JAR; Lopez RFV
Pharmazie; 2018 Mar; 73(3):133-138. PubMed ID: 29544559
[TBL] [Abstract][Full Text] [Related]
16. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study.
Khan MA; Pandit J; Sultana Y; Sultana S; Ali A; Aqil M; Chauhan M
Drug Deliv; 2015; 22(6):795-802. PubMed ID: 24735246
[TBL] [Abstract][Full Text] [Related]
17. Development of microsponges for topical delivery of mupirocin.
Amrutiya N; Bajaj A; Madan M
AAPS PharmSciTech; 2009; 10(2):402-9. PubMed ID: 19381834
[TBL] [Abstract][Full Text] [Related]
18. Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II.
Hussain A; Haque MW; Singh SK; Ahmed FJ
Drug Deliv; 2016 May; 23(4):1242-53. PubMed ID: 26697777
[TBL] [Abstract][Full Text] [Related]
19. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
[TBL] [Abstract][Full Text] [Related]
20. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.
Levy S; Furst K; Chern W
Cutis; 2002 Aug; 70(2 Suppl):14-21. PubMed ID: 12353676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
